{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T09:40:15Z","timestamp":1725183615220},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"DOI":"10.7759\/cureus.68364","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T09:20:11Z","timestamp":1725182411000},"source":"Crossref","is-referenced-by-count":0,"title":["Small Intestine Metastasis Leads to the Diagnosis of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report"],"prefix":"10.7759","author":[{"given":"Rei","family":"Sanai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoshi","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Ebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2023\/62583.18076","article-title":"An update on WHO classification of thoracic tumours 2021-newly described entities and terminologies","volume":"17","author":"Singh G","year":"2023","unstructured":"Singh G, Singh A, Dave R. An update on WHO classification of thoracic tumours 2021-newly described entities and terminologies. J Clin Diagnostic Res. 2023, 17:1-5. 10.7860\/jcdr\/2023\/62583.18076","journal-title":"J Clin Diagnostic Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter JL","year":"2017","unstructured":"Sauter JL, Graham RP, Larsen BT, Jenkins SM, Roden AC, Boland JM. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior. Mod Pathol. 2017, 30:1422-32. 10.1038\/modpathol.2017.61","journal-title":"Mod Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida A","year":"2017","unstructured":"Yoshida A, Kobayashi E, Kubo T, et al.. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities. Mod Pathol. 2017, 30:797-809. 10.1038\/modpathol.2017.11","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer F","year":"2015","unstructured":"Le Loarer F, Watson S, Pierron G, et al.. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat Genet. 2015, 47:1200-5. 10.1038\/ng.3399","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1273","article-title":"The SWI\/SNF complex-chromatin and cancer","volume":"4","author":"Roberts CW","year":"2004","unstructured":"Roberts CW, Orkin SH. The SWI\/SNF complex-chromatin and cancer. Nat Rev Cancer. 2004, 4:133-42. 10.1038\/nrc1273","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch C","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013, 45:592-601. 10.1038\/ng.2628","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00639-w","article-title":"Thoracic SMARCA4-deficient undifferentiated tumor","volume":"14","author":"Jiang J","year":"2023","unstructured":"Jiang J, Chen Z, Gong J, Han N, Lu H. Thoracic SMARCA4-deficient undifferentiated tumor. Discov Oncol. 2023, 14:51. 10.1007\/s12672-023-00639-w","journal-title":"Discov Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04359-6","article-title":"Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors","volume":"149","author":"Luo J","year":"2023","unstructured":"Luo J, Ding B, Campisi A, Chen T, Teng H, Ji C. Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors. J Cancer Res Clin Oncol. 2023, 149:4455-63. 10.1007\/s00432-022-04359-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0142","article-title":"Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report","volume":"12","author":"Iijima Y","year":"2020","unstructured":"Iijima Y, Sakakibara R, Ishizuka M, et al.. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report. Immunotherapy. 2020, 12:563-9. 10.2217\/imt-2019-0142","journal-title":"Immunotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13215","article-title":"Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report","volume":"10","author":"Takada K","year":"2019","unstructured":"Takada K, Sugita S, Murase K, et al.. Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report. Thorac Cancer. 2019, 10:2312-5. 10.1111\/1759-7714.13215","journal-title":"Thorac Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0311","article-title":"Atezolizumab with bevacizumab, paclitaxel\u00a0and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma","volume":"13","author":"Kawachi H","year":"2021","unstructured":"Kawachi H, Kunimasa K, Kukita Y, et al.. Atezolizumab with bevacizumab, paclitaxel\u00a0and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma. Immunotherapy. 2021, 13:799-806. 10.2217\/imt-2020-0311","journal-title":"Immunotherapy"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107818","article-title":"Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods","volume":"192","author":"Shi M","year":"2024","unstructured":"Shi M, Pang L, Zhou H, et al.. Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods. Lung Cancer. 2024, 192:107818. 10.1016\/j.lungcan.2024.107818","journal-title":"Lung Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac040","article-title":"Immune-desert tumor microenvironment in thoracic SMARCA4-deficient undifferentiated tumors with limited efficacy of immune checkpoint inhibitors","volume":"27","author":"Gantzer J","year":"2022","unstructured":"Gantzer J, Davidson G, Vokshi B, et al.. Immune-desert tumor microenvironment in thoracic SMARCA4-deficient undifferentiated tumors with limited efficacy of immune checkpoint inhibitors. Oncologist. 2022, 27:501-11. 10.1093\/oncolo\/oyac040","journal-title":"Oncologist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing","volume":"359","author":"Pan D","year":"2018","unstructured":"Pan D, Kobayashi A, Jiang P, et al.. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science. 2018, 359:770-5. 10.1126\/science.aao1710","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.350","article-title":"BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling","volume":"32","author":"Chaiyachati BH","year":"2013","unstructured":"Chaiyachati BH, Jani A, Wan Y, Huang H, Flavell R, Chi T. BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling. EMBO J. 2013, 32:395-408. 10.1038\/emboj.2012.350","journal-title":"EMBO J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz160","article-title":"Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor","volume":"30","author":"Henon C","year":"2019","unstructured":"Henon C, Blay JY, Massard C, et al.. Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. Ann Oncol. 2019, 30:1401-3. 10.1093\/annonc\/mdz160","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1532","article-title":"Intraluminal small bowel metastasis from primary lung cancer","volume":"13","author":"Kosciuszek ND","year":"2022","unstructured":"Kosciuszek ND, Noel P, Takabe K, Seitelman E, Datta R, Gunasekaran G, Takahashi H. Intraluminal small bowel metastasis from primary lung cancer. World J Oncol. 2022, 13:409-16. 10.14740\/wjon1532","journal-title":"World J Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-021-01627-z","article-title":"SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma","volume":"69","author":"Khanchel F","year":"2021","unstructured":"Khanchel F, Hedhili R, Zenaidi H, et al.. SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma. Gen Thorac Cardiovasc Surg. 2021, 69:1155-8. 10.1007\/s11748-021-01627-z","journal-title":"Gen Thorac Cardiovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286136-small-intestine-metastasis-leads-to-the-diagnosis-of-thoracic-smarca4-deficient-undifferentiated-tumor-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T09:20:14Z","timestamp":1725182414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286136-small-intestine-metastasis-leads-to-the-diagnosis-of-thoracic-smarca4-deficient-undifferentiated-tumor-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.68364","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}